Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Barnaby Pickering

Reporter, Medtech Insight

London, UK

Graduating in 2020 with a Master’s degree in biomedical engineering from University College London, Barnaby is passionate about all things medtech. In his first role as a journalist, Barnaby will focus on R&D and commercial stories in medtech, and writing about emerging technologies such as digital health, artificial intelligence, machine learning, deep-brain implants, and nanoscale applications of medtech. Alongside this, Barnaby is looking forward to taking deeper dives into start-ups, device market analysis, and company financial data, to create informed, useful, and engaging content.

Barnaby lives in in rural Wiltshire, UK and is a keen reader, cyclist, and hobbyist jeweler.

Latest From Barnaby Pickering

Execs On The Move: June 2022

An interactive view of medtech executive changes from the month of June.

Commercial Companies

Building Digital Platforms To Bridge Diabetes Care Gaps

Are digital solutions the missing link for diabetes care? Glooko and Omada Health think. Both have developed device-integrating platforms to help patients manage their condition.

Digital Health Telehealth

Minute Insight: SonALAsense MR-Guided Ultrasound Drug-Device Combo Trials Get Green Light

SonALAsense has received Safe to Proceed letters from the FDA to begin trials of its ultrasound-activated cancer killing drug.

Drug Delivery Technology Clinical Trials

Snapshot: June Highlights

A selection of articles you might have missed from June 2022, including a deep dive into venture finance, an in depth discussion about Russia's upcoming drug supply woes, and the latest Rising Leaders interviews.

New Science Market Intelligence

Paige Secures Eighth CE Mark For Cancer Identification AI

The Memorial Sloan Kettering spin-out has received CE-IVD and UKCA marks for its artificial intelligence software designed to identify HER2 expression in biopsies.

Platform Technologies Approvals

What Do Speedboats Have To Do with Surgery?

Nothing except a name, but Creo Medical says its Speedboat Inject device can turn some surgeries from prolonged hospital stays into one-day visits.

Platform Technologies Innovation
See All
UsernamePublicRestriction

Register